Clinical Trial Update: Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reporting sustained virological response to antiviral therapy in liver transplant recipients with recurrent hepatitis C, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hepatitis C, Liver Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2014-05-26